Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL389479 | 0.85 | GPR119 (0.73) | GPR119FAAH | |
| SCHEMBL386450 | 0.85 | GPR119 (1.00) | GPR119 | |
| SCHEMBL390465 | 0.80 | GPR119 (0.67) | GPR119 | |
| SCHEMBL4768567 | 0.76 | GPR119 (0.68) | GPR119 | |
| SCHEMBL389524 | 0.73 | GPR119 (0.73) | GPR119 | |
| SCHEMBL388346 | 0.73 | GPR119 (1.00) | GPR119 | |
| SCHEMBL905129 | 0.73 | GPR119 (0.65) | GPR119 | |
| SCHEMBL1243560 | 0.73 | GPR119 (0.79) | GPR119 | |
| SCHEMBL4414294 | 0.69 | GPR119 (0.63) | GPR119 | |
| SCHEMBL1244926 | 0.69 | GPR119 (0.50) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1808168-B1 | Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level | ARENA PHARM INC (US) | 2009-06-03 | — | — | EP | disclosed |